A rational approach for a phase I clinical study design to evaluate CNTO 95, a novel, fully human anti-avmonoclonal antibody (MAb), in patients with solid tumors

Autor:	H. M. Davis, U. Prabhakar, H. Jang, Q. Jiao, M. Trikha, J. Ford, C. Joel, A. Fasanmade, M. A. Graham
Rok vydání:	2004
Předmět:	Cancer Research Oncology
Zdroj:	Journal of Clinical Oncology. 22:2609-2609
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2004.22.90140.2609
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::484cb9ee2655784d1e59c13d6fa789ef https://doi.org/10.1200/jco.2004.22.90140.2609 Zobrazit plný text záznamu